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In recent  years,  afﬁnity  fusion-tag  systems  have become  a popular  technique  for  the  puriﬁcation  of  recom-
binant  proteins  from  crude  extracts.  However,  several  drawbacks  including  the  high  expense  and  low
stability  of ligands,  their  leakage  during  operation,  and  difﬁculties  in  immobilization,  make  it important  to
further  develop  the  method.  The  present  work  is  concerned  with  the  utilization  of a  ceramic  ﬂuorapatite
(CFT)-based  chromatographic  matrix  to  overcome  these  drawbacks.  A  heptapeptide  library  exhibiting  a
range of  properties  have  been  synthesized  and  subjected  to ceramic  ﬂuorapatite  (CFT)  chromatography
to  characterize  their retention  behavior  as a function  of pH and  composition  of the  binding  buffer.  The
speciﬁc  binding  and  elution  behavior  demonstrates  the  possible  application  of CFT-binding  peptides  as
tags  for  enhancing  the  selective  recovery  of  proteins  by  CFT  chromatography.  To  materialize  this  strategy,
a phage-derived  CFT-speciﬁc  sequence  KPRSVSG  (Tag1)  with/without  a  consecutive  hexalysine  sequence,
KKKKKKKPRSVSG  (Tag2),  were  fused  at the  C-terminus  of  an  enhanced  green  ﬂuorescent  protein  (eGFP).
The resulting  gene  constructs  H-eGFP,  H-eGFP-Tag1  and  H-eGFP-Tag2  were  expressed  in Escherichia  coli
strain  BL-21,  and  the clariﬁed  cell lysate  was  applied  to  the CFT  column  equilibrated  with  binding  buffer
(20–50  mM  sodium  phosphate,  pH  6–8.4).  Sodium  phosphate  (500  mM)  or 1 M NaCl  in the  respective
binding buffer  was  used  to elute  the  fused  proteins,  and  the  chromatographic  fractions  were  analyzed  by
gel electrophoresis.  Both  the  yield  and purity  were  over  90%,  demonstrating  the  potential  application  of
the  present  strategy.
ublis©  2014  The  Authors.  P
. Introduction
Recombinant protein-based drugs are already signiﬁcant com-
onents of the therapeutic arsenal. They contribute greatly to the
apid growth of biopharmaceuticals in the ﬁeld of medicine [1–4].
owever, the puriﬁcation of recombinant proteins from crude
xtracts, that represents the largest portion of the entire cost of
ioprocessing still remains as a major bottleneck in biopharma-
eutical industries [5,6]. As a consequence, a raise in the product
rice, and a decrease in the pace of its development, limit the acces-
ibility of those products to the patients. In this context, afﬁnity
usion-tag methods arise as popular tools for the puriﬁcation of
∗ Corresponding author at: Department of Biochemical Engineering, School of
ngineering and Science, Jacobs University Bremen, Campus Ring 1, 28759 Bremen,
ermany. Tel.: +49 421 200 3239; fax: +49 421 200 3249.
E-mail address: m.fernandez-lahore@jacobs-university.de
M.  Fernandez-Lahore).
ttp://dx.doi.org/10.1016/j.chroma.2014.02.079
021-9673/© 2014 The Authors. Published by Elsevier B.V. This is an open access article unhed  by  Elsevier  B.V. This  is  an  open  access  article  under  the  CC  BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
recombinant proteins [7–9]. These methods entail a generic strat-
egy for the single-step puriﬁcation of the fused proteins from a
complex biological mixture [10,11].
The small peptide tags share some distinct beneﬁcial features,
for example they have minimal effects on the structure and bioac-
tivity of proteins [12], they act simply in terms of puriﬁcation
[13], and they can be removed speciﬁcally to produce the native
protein [14]. Moreover, various proteins can be puriﬁed using a
common method [15]. Immobilized metal ions [16], proteins [17],
antibodies [18], and complementary peptides [19] are the most
commonly used ligands in this type of chromatography. However,
some limiting factors such as the difﬁculties in ligand immobiliza-
tion [20]; the possibility of metal ion leakage [12]; the low stability
of protein or antibody ligands [14]; and the possible contamination
of the ﬁnal product [21], show the necessity for further develop-
ment of this method.
Calcium phosphate based ceramic apatites have been widely
used as leading adsorbent of biomolecules [22–24]. Apatite
(AP) chromatographic matrix itself shows functionalities toward
der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
atogr. A 1339 (2014) 26–33 27
b
M
c
ﬂ
o
l
o
r
n
i
r
e
e
d
a
e
I
t
w
o
c
t
o
r
j
e
t
m
i
d
e
(
p
I
t
i
w
f
c
e
e
2
2
w
U
a
d
(
a
r
f
B
g
c
a
t
(
r
t
Table 1
Sequence and molecular weight (MW)  of the enhanced green ﬂuorescent protein
(eGFP) and the eGFP constructs.
Construct Sequence MW (kDa)
eGFP MSRVSKGEELFTGVVPILVELDGDVNGHKFSVSGE
GEGDATYGKLTLKFICTTGKLPVPWPTLVTTLTYGV
QCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDD
GNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGH
KLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDG
SVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKD
PNEKRDHMVLLEFVTAAGITLGMDELYK
27.2
H-eGFP MHHHHHH-eGFP 28
H-
eGFP-
Tag1
MHHHHHH-eGFP-KPRSVSG 28.75
H- MHHHHHH-eGFP-KKKKKKKPRSVSG 29.5T. Islam et al. / J. Chrom
iomolecules [25–27], so there is no need of ligand immobilization.
oreover, the components of AP materials are neither antigenic nor
ytotoxic [28]. Therefore, it is expected that utilization of ceramic
uorapatite (CFT) stationary phase in afﬁnity-tag systems may
vercome some of the traditional drawbacks as mentioned ear-
ier. A model approach is presented here to verify the applicability
f CFT-binding peptides (CBPs) as tags to enhance the selective
ecovery of proteins by CFT chromatography.
Retention of biomolecules on AP surfaces is mainly domi-
ated by phosphoryl cation exchange and calcium ion regulated
nteractions [25,29]. However, previous studies also reported that
etention of some positively charged biomolecules cannot be
xplained by a simple cation exchange mechanism [30,31]. Inter-
stingly, some AP materials retain negatively charged biomolecules
espite their net negative surface charge; the interaction mech-
nisms are less clear albeit [29]. The complexity in interactions
ventually makes the AP surface selective for speciﬁc biomolecules.
n previous work, we have identiﬁed CFT-speciﬁc heptamer pep-
ides from phage display selection [32]. The peptide F5-4, KPRSVSG,
as the most frequent among the phage-derived CBPs, and it was
bserved that peptide F5-4 can be eluted speciﬁcally from the CFT
olumn. The speciﬁc retention behavior of the CBPs illuminates
he possibility for their use as tags in CFT chromatography. The
bjective of the present work was to verify this strategy.
The well-known green ﬂuorescent protein (GFP) with a typical
igid beta barrel structure, ﬁrst isolated from the bioluminescent
ellyﬁsh Aequorea victoria, exhibits bright green ﬂuorescence when
xposed to light in the blue to ultraviolet range [33,34]. Due to
his particular property, GFP has been widely used to monitor pro-
oter activity, the localization and motility of proteins, and the
nteractions between biomolecules in vivo or in vitro [35–37]. In
ownstream processing, GFP is often utilized to investigate the
fﬁciency of tags [11,38,39]. Here, an enhanced mutant of GFP
eGFP) [40], a 241-amino acid protein with improved ﬂuorescent
roperties was used to investigate the efﬁciency of CBPs as tags.
n this work, CBPs were fused genetically at the C-terminus of
he eGFP and the resulting gene constructs were then expressed
n Escherichia coli (E. coli). Afterwards, the clariﬁed cell lysates
ere applied to the CFT column and the retention behavior of the
used proteins was determined under different chromatographic
onditions. The chromatographic fractions were subjected to gel
lectrophoresis, and the performance of the current strategy was
valuated by analyzing the gel images.
. Materials and methods
.1. Materials
Ceramic ﬂuorapatite (40 m particle size, 600–800 A˚ pore size)
as purchased from BioRad Laboratories (Hercules, California,
SA). Preloaded Wang resin, Fmoc (9-ﬂuorenylmethoxycarbonyl)-
mino acid derivatives, N-methylpyrrolidone (NMP), piperi-
ine, 1-hydroxybenzotriazole (HOBt), N,N-diisopropylethylamine
DIEA), O-(benzotriazol-1-yl)-N,N,N’,N’-tetramethyluronium hex-
ﬂuorophosphate (HBTU), dimethylformamide (DMF), triﬂuo-
oacetic acid (TFA), and 1,2-ethanedithiol (EDT) were purchased
rom Iris Biotech GmbH (Marktredwitz, Germany). E. coli strain
L21 was obtained from Life Technologies (New York, USA). The
ene corresponding to enhanced green ﬂuorescent protein (eGFP),
ontaining the peptide sequence HHHHHH (H6) on the N-terminus
nd with or without the CFT-speciﬁc peptide sequences on the C-
erminus, was synthesized and cloned in the pUC18 by GenScript
Piscataway, USA). The sequence and molecular weight (MW)  of the
esulting constructs are shown in Table 1. It has been demonstrated
hat GFP containing a poly-histidine (H6) tag does not bind to APeGFP-
Tag2
materials [39], therefore, a H6-tag was fused to eGFP constructs
here to monitor their expression by immobilized-metal afﬁnity
chromatography (IMAC). Reagents and instruments used for the
gel electrophoresis were obtained from GE Healthcare (New Jersey,
USA). All other chemicals and reagents were analytical grade.
2.2. Peptide synthesis
Peptide synthesis was  carried out on an automated peptide
synthesizer (ABI-433A, Applied Biosystems, California, USA) using
the standard solid phase peptide synthesis (SPPS) method [41].
Fmoc protecting group was  removed from the N-terminal of the
preloaded resin bound amino acid by 20% piperidine in NMP, and
the C-terminal of another Fmoc-amino acid was activated using
HOBt/HBTU/DIEA (1:1:2) in DMF. Afterwards, the activated amino
acid was  allowed to react with the deprotected N-terminal of the
resin bound amino acid. A cleavage cocktail (82.5% TFA, 5% phenol,
5% water, 5% thioanisol and 2.5% EDT) was  used to separate the
desired peptide from the resin as well as to remove the acid-labile
side chain protecting groups.
2.3. Mass spectrometry
The molecular masses of the synthesized peptides were checked
by matrix assisted laser desorption/ionization time-of-ﬂight
(MALDI-ToF) mass spectrometry (Autoﬂex II, Bruker Daltonics,
Bremen, Germany). The MALDI-ToF analysis was  performed in
positive-ion mode using a HCCA (-cyano-4-hydroxycinnamic
acid) matrix prespotted AnchorChip target (Bruker Daltonics, Bre-
men, Germany). Peptide sample was  dissolved in 1% TFA at a
concentration of 1 mg/mL, diluted 10 times, and 2 L of peptide
solution was applied on the spot. Afterwards, the sample plate was
injected into the MALDI-ToF instrument. At the beginning of the
analysis, calibration was  run with standard peptide sample, and
the acquired calibration data was applied to the measurements of
real samples for the mass correction.
2.4. Characterization of the retention of the peptides in CFT
chromatography
The chromatographic experiments were performed on BioCAD®
700E (Applied Biosystems, Foster City, USA) equipped with a
fraction collector (FC 203B, Gilson, Middleton, USA) and with
a UV detector set at 214 nm.  A Tricorn column (5/50, GE
Healthcare, Munich, Germany) was  packed with 20% slurry
(w/v) of the CFT beads in degassed 200 mM sodium phosphate
(Na2HPO4 + NaH2PO4), pH 9.2. The experiments were carried out
at pH 7.4. Here 5–20 mM sodium phosphate (Na-phosphate) and
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Table 2
Inﬂuence of the composition of the binding buffer on the retention of the peptides
in  CFT column chromatography.
Peptide ID (sequence)a 5 mM NaP 10 mM NaP 20 mM NaP TBS (1%)
N0 (HLPPWTQ) − − − − − − − − − − − −
E1 (LHSELPT) − − − − − − − − − +++
D1 (DHPAVAQ) − − − − − − − − − +++
E2 (GSESEGG) Negligible − − − − − − +++
D4 (DDDDGGG) +++ − − − − − − +++
E6 (EEEEEEG) +++ Negligible − − − +++
K1 (KTTGLTV) − − − − − − − − − +++
K2 (SKTKNNL) +++ +++ +++ +++
K4 (KKKKGGG) +++ +++ +++ +++
K6 (KKKKKKG) +++ +++ +++ +++
R1 (SQMHLRY) − − − − − − − − − +++
K1R1 (KPRSVSG) +++ +++ +++ +++
R2 (QRHTRPN) +++ +++ +++ +++
R4 (RRRRGGG) +++ +++ +++ +++
NDK (SSPDKSF) − − − − − − − − − +++
NEK (KKTPEEG) +++ − − − − − − +++8 T. Islam et al. / J. Chrom
% TBS (50 mM Tris–HCl pH 7.5, 150 mM NaCl) were used as the
inding buffers (buffer A), and the experiments were run at a ﬂow
ate of 1 mL/min. The CFT column was equilibrated properly with
uffer A, then 500 L of the peptide sample (2 mg/mL) was injected,
he column was washed with buffer A (5 mL). Afterwards, a gradi-
nt elution was performed with 20 mL  of 600 mM Na-phosphate
buffer B).
.5. Production of the fusion protein
The eGFP gene constructs H-eGFP, H-eGFP-Tag1, and H-eGFP-
ag2 were expressed in E. coli strain BL-21. Single colonies of
ransformed E. coli harboring the eGFP gene construct were picked
rom ampicillin plates and inoculated into 10 mL  of media contain-
ng ampicillin (0.1 mg/mL). The overnight incubation was carried
ut on a shaker at 37 ◦C. The overnight culture was inoculated
nto a 1 L media containing ampicillin (0.1 mg/mL). The culture was
rown to OD600 0.9–1.0 in a shaker at 37 ◦C, and eGFP expression
as induced with the addition of IPTG to a ﬁnal concentration of
.25 mM.  After overnight growth at 28 ◦C, the cells were harvested
y centrifugation at 5000 × g and resuspended in 20 mL  of lysis
uffer (50 mM Na-phosphate, pH 7.4). The suspension was lysed
hrough pulsed sonication using a Branson Soniﬁer 150 (Branson
ltrasonics Corporation, Connecticut, USA) on ice for 5 min. The
ysate was centrifuged at 10,000 × g for 20 min  at 4 ◦C, and the
emaining cellular debris was discarded.
.6. Fluorescense microscopy
The eGFP constructs H-eGFP, H-eGFP-Tag1, and H-eGFP-Tag2
xpressing cells were monitored using a ﬂuorescence microscope
Axiovert 200, Carl Zeiss, New York, USA) equipped with ﬁlter 8
GFP range). The induced cell culture samples were centrifuged at
000 × g for 3 min, and the pellets were washed with phosphate
uffer saline (PBS) (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4,
 mM KH2PO4). Afterwards, the pellets were suspended gently in
BS buffer. The suspension was transferred to a glass slide and sub-
ected to analysis under the microscope. The images were captured
t a magniﬁcation of 100 by Axiocam MRc  (Carl Zeiss, New York,
SA).
.7. Evaluation of protein expression
The expression of designed constructs was examined by ana-
yzing the cell lysate supernatant via IMAC. An aliquot of the
upernatant was  loaded onto a metal chelate spin column (Nunc
roPur IMAC spin columns, Thermo Scientiﬁc, IL, USA). The col-
mn  was pre-equilibrated with ﬁve column volumes of lysis
uffer containing 10 mM imidazole. After washing with the same
uffer containing 30 mM imidazole, elution was performed with
50 mM imidazole. The crude extracts and eluate fractions were
nalyzed with 12.5% sodium dodecyl sulfate-polyacrylamide gel
lectrophoresis (SDS-PAGE). Coomassie brilliant blue staining was
sed to detect the protein bands in the gel.
.8. Puriﬁcation of the fused proteins by CFT column
hromatography
Puriﬁcation of the fused proteins was carried out on AKTAprime
lus (GE Healthcare). A 20% slurry (w/v) of CFT beads in a degassed
acking buffer (200 mM Na-phosphate, pH 9.2) was used to pack
 Tricorn column (5/50, GE Healthcare). Na-phosphate and NaCl
radient elutions were performed with increasing salt concentra-
ions. For the Na-phosphate elution, the binding buffer (buffer A)
as 20–50 mM Na-phosphate and the elution buffer (buffer B)
as a 500 mM Na-phosphate. For the NaCl elution, buffer A wasa Amino acids are presented as single letter in the sequences.
NaP represents sodium phosphate buffer.
(+++) represents retained and (− − −) represents non-retained.
20 to 50 mM Na-phosphate and buffer B was 1 M NaCl in 20 mM
Na-phosphate. At the beginning of each experiment, the CFT col-
umn was  equilibrated properly with buffer A. The cell lysate was
diluted four times with 10 mM Na-phosphate, pH 7.4, and 5 mL  of
the diluted cell lysate (sample) was  loaded onto the column. After-
wards, the column was  washed with buffer A (10 mL), a gradient
elution was  performed with 0 to 100% buffer B (20 mL), and the col-
umn  was washed with 100% buffer B. The experiments were run at
a ﬂow rate of 1 mL/min. After each run, the column was regenerated
with 500 mM Na-phosphate. The crude extracts, ﬂow-through, and
elution fractions were analyzed by 12.5% SDS-PAGE. Protein bands
were visualized by silver staining.
3. Results
3.1. Peptide synthesis and analysis
In our previous work, CBPs were identiﬁed from a randomized
heptamer phage display peptide library. Peptides with diversi-
ﬁed physico-chemical properties have been found in the selected
phage-derived sequences. Therefore, it is difﬁcult to predict their
retention mechanism in CFT chromatography. However, peptides
that will be used as tags should have speciﬁc retention behavior.
For this reason, an investigation was performed to understand the
underlying facts behind the retention of peptides on CFT (Table 2).
Peptides exhibiting a range of properties, such as, acidic amino
acid rich peptides E1 (LHSELPT), D1 (DHPAVAQ), E2 (GSESEGG),
D4 (DDDDGGG), E4 (EEEEGGG) and E6(EEEEEEG), basic amino acid
rich peptide K1 (KTTGLTV), K2 (SKTKNNL), R1 (SQMHLRY), R2
(QRHTRPN), R4 (RRRRGGG), K4 (KKKKGGG) and K6 (KKKKKKG), and
neutral peptide N0 (HLPPWTQ), NDK (SSPDKSF) and NEK (KKTPEEG)
were synthesized and subjected to CFT chromatography under dif-
ferent conditions. Here, the sequence ID that starts with ‘F’ was
selected from phage display selection.
3.2. Characterization of the retention of the peptides in CFT
chromatography
Retention of the peptides on CFT was veriﬁed with 5, 10 and
20 mM Na-phosphate binding buffer at pH 7.4. Table 2 represents
the effects of the composition of the mobile phase on peptide
binding to CFT in dynamic condition. Neutral peptide N0 and
the positively charged peptides (K1 and R1) having a net charge
of +1 were not retained in any composition of Na-phosphate
T. Islam et al. / J. Chromatogr. A 1339 (2014) 26–33 29
Table  3
Inﬂuence of net charge and isoelectric point on the retention of peptides on CFT.
Peptide ID (sequence) Isoelectric point Net charge Sodium phosphate concentration (mM) at the
point of elution at pH 7.4
TBS (1%)a 20 mM NaPa
E1 (LHSELPT) 5.1 −1 170 –
E4 (EEEEGGG) 3 −4 185 –
D4 (DDDDGGG) 2.75 −4 190 –
E6 (EEEEEEG) 2.9 −6 195 –
K1R1 (KPRSVSG) 11.5 +2 240 220
E2K4 (EEKKKKG) 10.2 +2 260 235
K4 (KKKKGGG) 11 +4 355 340
R4 (RRRRGGG) 12.9 +4 290 275
K6 (KKKKKKG) 11.2 +6 465 445
N (KKTPEEG) 7.05 0 180 –
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Fig. 1. Comparison between the compositions of the mobile phase required for
the elution of the peptides. Buffer A was 1% of TBS and buffer B was 600 mM Na-EK
a Binding buffer at pH 7.4.
aP represents sodium phosphate.
inding buffer. However, the column with 5 mM Na-phosphate
uffer retained the neutral peptide NEK. The positively charged
eptides having a net charge of +2 or more were retained in all
pplied compositions of the binding buffer. Interestingly, none of
he acidic peptides were retained by the column when the binding
uffer was 10 or 20 mM  Na-phosphate. Therefore, 1% of TBS buffer
as considered as binding buffer for observing the effect of differ-
nt types of binding buffers on retention. In this case, all peptides
ut N0 were retained by the column.
A gradual elution was performed with 600 mM Na-phosphate,
H 7.4. The peptides E1, D4, E4, E6, NDK, NEK, K1R1, R4, K4 and K6
ere eluted with approximately 170, 190, 185, 195, 175, 180, 240,
75, 355 and 465 mM Na-phosphate, respectively, when the bind-
ng buffer was 1% TBS. The effects of the net charge and isoelectric
oint (IEP) of the peptides on retention are shown in Table 3. The
omposition of the buffer at the point of elution of neutral peptide
DK or NEK was very similar to that of the acidic peptides. There-
ore, it is suggested that the retention of NDK or NEK was mainly
ominated by the interactions between glutamic acid (E) and cal-
ium ions (Ca+2) on the CFT surface. This clearly shows that Ca+2
C-site) regulated interactions do not depend on the net charge of
eptides, whereas phosphate (P-site) regulated interactions on the
FT surface do depend on the net charge of peptides [42]. Some
nteresting features were observed regarding the effect of different
ypes of acidic or basic amino acid residues, the retention times
RTs) of the lysine (K) containing peptides were longer than that
f the arginine (R) containing peptides, whereas the RTs of acidic
mino acid (D and E) containing negatively charged or neutral pep-
ides were similar. However, it was not possible to correlate the
etention behavior and IEP values of the peptides [29].
A comparison between salt concentrations required to elute the
harged peptides from the CFT column is shown in Fig. 1. This fea-
ure of binding and elution deﬁnitely indicates some of the beneﬁts
egarding the use of positively charged peptides as tags for the
uriﬁcation of recombinant proteins by CFT chromatography [9].
t can be assumed that the composition of the mobile phase can
e selected to restrict the retention of negative charged proteins
s has been demonstrated with negatively charged peptides, and
he proteins fused with positively charged peptides could be eluted
peciﬁcally from the CFT column. This hypothesis shows the pos-
ible application of the most frequent phage-derived CFT-binding
eptide F-4 (KPRSVSG) as tag.
.3. Production of the fusion proteinsThe eGFP constructs (Table 1) were expressed in E. coli, and
he protein expressing cells were monitored by ﬂuorescence
icroscopy after 8 h of IPTG induction. The presence of the designedphosphate. A gradient elution was performed with 0–100% buffer B (20 mL), and the
experiments were run at pH 7.4 with a ﬂow rate of 1 mL/min.
constructs in the supernatant was  investigated with immobilized
metal ion afﬁnity chromatography (IMAC). The crude lysate and
the elution fractions from the IMAC spin column were subjected to
the SDS-PAGE analysis. The protein bands of H-eGFP, H-eGFP-Tag1
and H-eGFP-Tag2 corresponded to their approximate theoretical
molecular weight (MW)  of 28, 28.75 and 29.5 respectively. Fig. 2
represents the SDS-PAGE image of the crude extracts and the
respective eluate fraction from IMAC.
3.4. Puriﬁcation of H-eGFP-Tag1 by CFT chromatography
The retention of the designed constructs on the CFT surface was
investigated through chromatographic experiments. A Tricorn col-
umn  (5/50) was  packed with CFT beads, and the experiments were
run at a ﬂow rate of 1 mL/min. Here, 20 mM Na-phosphate was
used as the binding buffer (buffer A), and the experiments were
performed at a pH ranging from 6 to 8.4. A four-fold diluted cell
lysate (5 mL)  was  passed through the column, and the elution was
performed with 1 M NaCl in the respective binding buffer. Con-
struct H-eGFP-Tag1 was  eluted with approximately 550 mM NaCl
in 20 mM Na-phosphate at pH 6.5. The crude extract, ﬂow through
and eluate fractions were analyzed with SDS-PAGE, and this analy-
sis shows that the construct was  separated by the CFT column with
high purity and yield. Fig. 3(A) represents the chromatographic
proﬁle and Fig. 3(B) represents the corresponding SDS-PAGE anal-
ysis for the puriﬁcation of H-eGFP-Tag1 at pH 6.5. A sharp protein
band corresponds to the approximate MW (28.75) of H-eGFP-Tag1
30 T. Islam et al. / J. Chromatogr. A 1339 (2014) 26–33
Fig. 2. SDS-PAGE analysis (Coomassie brilliant blue staining) of the cell lysate and
the corresponding eluate fractions obtained from the IMAC spin column. Lanes: 1,
molecular weight markers; 2, lysate of E. coli cells expressing H-eGFP; 3, eluate
fraction containing H-eGFP; 4, lysate of the H-eGFP-Tag1 expressing E. coli cells; 5,
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Table 4
Effect of pH on the retention of the constructs.
Binding buffer pH H-eGFP H-eGFP-Tag1 H-eGFP-Tag2
20 mM sodium
phosphate
6 − − − +++ +++
6.5 −  − − +++ +++
7  − − − +++ +++
7.4  − − − Negligible +++
CFT column with approximately 430 mM Na-phosphate or 850 mM
F
(
b
wluate fraction containing H-eGFP-Tag1; 6, lysate of the H-eGFP-Tag2 expressing
. coli cells; 7, eluate fraction containing H-eGFP-Tag2.
s found in cell lysate (lane 2) and eluted fractions (lane 4). Whereas
 very tiny band of H-eGFP-Tag1 is found in the ﬂow through frac-
ion (lane 3), and apparently no other signiﬁcant protein bands are
isible in lane 4 expect the band for H-eGFP-Tag1. This clearly indi-
ates the high efﬁciency of the present approach that can separate
 target protein with a purity of over 90%.
Table 4 represents the effect of pH on the retention of the con-
tructs. The retention of H-eGFP-Tag1 decreased signiﬁcantly when
he experiments were performed at a pH beyond 7, and apparently,
here was no retention at pH 7.4. In Section 3.2, it was  observed
hat the electrostatic interactions play a key role behind the afﬁnity
f Tag1 toward CFT. Therefore, the pH dependent retention might
ig. 3. (A) Chromatographic proﬁle and (B) the corresponding SDS-PAGE results for the pu
5/50)  was packed with the CFT beads, and the experiments were run at a ﬂow rate of 1
uffer  (buffer B) was 1 M NaCl in 20 mM Na-phosphate. After sample (5 mL)  loading, the
ith  buffer B (20 mL).8.4  − − − − − − +++
(+++) represents retained and (− − −) represents non-retained.
be due to an alteration of the net surface charge of CFT and H-
eGFP-Tag1 [29]. It is certain that the positive charge density of
the construct is lower than that of the original peptide. The lower
surface charge density of H-eGFP-Tag1 might reduce the strength
of the interactions between CFT and the construct at higher pH
conditions. Therefore, the construct was  washed out through the
column instead of being adsorbed. This indicates that the success-
ful implementation of this technique requires the optimization of
chromatographic conditions.
3.5. Puriﬁcation of H-eGFP-Tag2 by CFT chromatography
The retention behavior of the peptides shows that peptides
composed of lysine residue have higher RTs than other pep-
tides. Therefore, six lysine residues (K6) were fused together
with Tag1, KKKKKKKPRSVSG (Tag2), for conducting the puriﬁ-
cation at elevated pH. In this case, 20 or 50 mM Na-phosphate
was used as the binding buffer (buffer A), a four-fold diluted
cell lysate (5 mL)  was passed through the column, and the
elution was  performed with 500 mM Na-phosphate or 1 M
NaCl in the respective binding buffer. Fig. 4 represents the
chromatographic proﬁle for the puriﬁcation of the H-eGFP-Tag2 at
pH 7.4. Two major peaks were found in the chromatograms during
elution, especially in the case of Na-phosphate elution. However,
there was a sufﬁcient distance between two peaks, indicating a dif-
ference in retention properties between the proteins corresponding
to the ﬁrst and second peaks. The presence of the construct H-eGFP-
Tag2 in the second peak was conﬁrmed through SDS-PAGE analysis,
which is represented in Fig. 5. The construct was  eluted from theNaCl at pH 7.4 when buffer A was 20 mM Na-phosphate. Approx-
imately 420 mM Na-phosphate or 800 mM NaCl was required to
elute the construct when buffer A was  50 mM Na-phosphate.
riﬁcation of construct H-eGFP-Tag1 by the CFT column at pH 6.5. A Tricorn column
 mL/min. The binding buffer (buffer A) was 20 mM Na-phosphate and the elution
 column was washed with buffer A (10 mL), and a gradient elution was  performed
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Fig. 4. Chromatograms obtained for the puriﬁcation of H-eGFP-Tag2 at pH 7.4 when the elution buffer was (A) 1 M NaCl or (B) 0.5 M Na-phosphate in the respective binding
buffers.  (—)  20 and (—) 50 mM Na-phosphate were used as the binding buffers (buffer A). A Tricorn column (5/50) was packed with CFT beads, and the experiments were run
at  a ﬂow rate of 1 mL/min. After sample loading (5 mL), the column was washed with buffer A (10 mL), and a gradient elution was performed with increasing concentration
of  NaCl or Na-phosphate (20 mL). After each run, the column was  washed with elution buffer (10 mL).
Fig. 5. SDS-PAGE analysis (silver staining) of the eluate fractions obtained from the CFT column for the puriﬁcation of H-eGFP-Tag2 at pH 7.4 (Lane 1–8) and at pH 8.4 (Lane
9  and 10). Lanes: 1, molecular weight markers; 2, lysate of the H-eGFP-Tag2 expressing E. coli cells; 3, column ﬂow through when the binding buffer (buffer A) was 20 mM
Na-phosphate at pH 7.4; 4 and 5, eluate fractions when buffer B was  500 mM Na-phosphate or 1 M NaCl in the respective buffer A; 6, column ﬂow through when buffer A
was  50 mM Na-phosphate at pH 7.4; 7 and 8, eluate fraction when buffer A was 50 mM Na-phosphate at pH 7.4, and buffer B was  500 mM Na-phosphate or 1 M NaCl in the
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tespective buffer A; 9, column ﬂow through when the buffer A was 20 mM Na-pho
uffer  A.
These results show that increasing increments of Na-phosphate
oncentration from 20 to 50 mM in the binding buffer (buffer A) did
ot have much inﬂuence on the retention of H-eGFP-Tag2. How-
ver, SDS-PAGE analysis (Fig. 5) of the eluted fractions showed
hat a higher purity was obtained when buffer A was 20 mM
a-phosphate. It can be assumed that a slightly higher salt con-
ent in buffer A might have reduced the intra- or intermoleculare at pH 8.4; 10, eluate fraction at pH 8.4 when buffer B was 1 M NaCl in respective
interactions of some proteins [43,44]. Therefore, the functional
groups on the surface of those proteins became available for inter-
action with the CFT, and thus the RTs of some of those proteins were
close to the RT of the H-eGFP-Tag2.
In order to further broaden the investigation regarding inter-
action mechanisms; the chromatographic experiments were
performed at higher pH conditions. Fig. 6 represents the
32 T. Islam et al. / J. Chromatogr
Fig. 6. Chromatograms obtained for the puriﬁcation of H-eGFP-Tag2 at pH 8.4. In
this  case, the clariﬁed lysate (non-diluted) was directly applied to the CFT column. A
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cricorn column (5/50) was  packed with the CFT beads, and the experiments were run
t  a ﬂow rate of 1 mL/min. The binding buffer (buffer A) was 20 mM Na-phosphate
nd  the elution buffer was 1 M NaCl in 20 mM Na-phosphate.
hromatogram when the experiments were run at pH 8.4. In this
xperiment, cell lysate (non-diluted) was directly subjected to
he column. The construct H-eGFP-Tag2 was eluted with approxi-
ately 825 mM NaCl in 20 mM Na-phosphate. The elution fraction
as subjected to SDS-PAGE analysis (Fig. 5), which conﬁrmed a
igh degree of puriﬁcation. Interestingly, there was  no signiﬁ-
ant difference between the salt concentrations required to elute
he construct at pH 7.4 and 8.4. Moreover, at both pH conditions,
he SDS-PAGE analysis shows that both the purity and yield were
bove 90% when buffer A was 20 mM Na-phosphate. For the deter-
ination of yield more precisely, the ratio of the construct in
ow-through fraction to the corresponding eluted fraction was
easured by a ﬂuorescent spectrophotometer (F-2500, Hitachi,
apan), which indicated an overall yield of 90–94%.
. Discussion
Due to the complex physico-chemical properties of proteins and
he possibility of denaturation, their puriﬁcation is a challenging
ask [45]. The structure and biological activities of proteins can be
ltered at any step of the puriﬁcation process, however an efﬁcient
ethod needs to yield high activity and recovery of the isolated
roteins [46]. In this context, small peptide afﬁnity-tag systems
re capable of reaching the objective of maximizing purity and
ield without effecting the tertiary structure and biological activ-
ty of most of the proteins [19,47]. The present work is focused on
urther development of this technique using ligand-less CFT sta-
ionary phase in this type of chromatography to overcome some
f the traditional drawbacks such as leakage and inactivation of
igands, high expense, possible contamination of the ﬁnal product
y residual ligand coupling reagents, and the subsequent environ-
ental burden [48,49]. As a ﬁrst step to materialize the concepts
roposed above, peptides with the ability to bind to CFT were dis-
overed in our previous work [32]. Yet, the peptides that will be
sed as tags should have speciﬁc retention behavior [11,50]. There-
ore, a peptide library with diversiﬁed physico-chemical properties
as been synthesized here and subjected to CFT chromatography.
he effects of net charge, isoelectric point and type of amino acid
ontent of the peptides on their binding to CFT were evaluated.
verall, the retention behavior of the peptides indicates that the
ositively charged peptides having net charge +2 or more can be
peciﬁcally eluted from the CFT column, which is important when
onsidering them for use as tags for the puriﬁcation of recombinant
roteins. Moreover, the retention time of the consecutive lysine
ontaining peptide was longer than other peptides. Therefore, a. A 1339 (2014) 26–33
phage derived positively charged peptide F5-4, KPRSVSG, with or
without a hexalysine sequence, KKKKKKKPRSVSG, were fused at
the C-terminus of the eGFP.
The intense green color of the eluted fraction from the CFT col-
umn  implies that both Tag1 and Tag2 sustained their CFA-binding
ability without affecting the ﬂuorescent properties of the fused pro-
tein. The retention of the construct H-eGFP-Tag1 on CFT decreased
signiﬁcantly when the experiments were run at pH above 7. How-
ever, the native Tag1 was  retained by the CFT column at pH 7.4. On
the other hand, at pH 6.5, interactions between H-eGFP-Tag1 and
CFT surface were stronger than the interactions between the native
Tag1 and the CFT surface [32]. This clearly indicates the partial pos-
itive charge contribution of the N-terminal histidine residues H6 to
the net charge of the construct at pH lower than 7.
Two major peaks were found in the chromatograms obtained
for the construct H-eGFP-Tag2. The second peak corresponded to
the construct; however the retention properties of the proteins of
the ﬁrst peak are not clear. Nevertheless, the relative area of the
ﬁrst peak decreased with the increase of Na-phosphate content
or pH of the binding buffer. In the section 3.2, it was observed
that 20 mM Na-phosphate, pH 7.4 was  able to prevent interac-
tions between CFT and six glutamic or aspartic acid containing
peptides or the peptides bearing a net positive charge of +1. There-
fore, it can be assumed that proteins corresponding to the ﬁrst
peak contain surface exposed positively charged or highly nega-
tively charged binding sites or phosphate groups. In this case, the
positively charged binding sites should bear a net charge of +2 or
+3. However, the positively charged proteins or binding sites might
contain acidic amino acids that can interact with the C-site (Ca+2) of
CFT. Therefore, the interactions between those proteins and CFT are
expected to be of a mixed mode, and thus compared to NaCl elution,
the ﬁrst peak area was higher with the Na-phosphate elution at pH
7.4, as the phosphate ion is a much stronger eluent than the chlo-
ride ion to break the bonds between proteins and the C-site of CFT.
It has been reported that the interactions between proteins and the
C-site of apatite (AP) materials increase with the increment of pH
of the mobile phase, while the interactions between proteins and
the P-site (PO43−) of AP materials decrease [29,31]. Therefore, it can
be hypothesized that the biomolecules corresponding to the ﬁrst
peak are a mixture of positively and negatively charged proteins.
The lower area of the ﬁrst peak at pH 8.4 can be explained by the fact
that the NaCl in the elution buffer was not able to elute the proteins
that were strongly associated with the C-site of CFT under elevated
pH conditions. On the other hand, at pH 6.5, the C-site interactions
decreased and some of those proteins that interacted with the P-
site of CFT might elute with construct H-eGFP-Tag1, so there were
no separate peaks. This assumption can also be supported by a pro-
tein band near 50 kDa found in the SDS-PAGE analysis of the eluted
fractions during the puriﬁcation of H-eGFP-Tag1 (Fig. 3B).
In this work, an IMAC spin column was used to ensure the
expression of the desired constructs. Still, it might be possible to
compare the efﬁciency between IMAC and the present strategy to
some degree. The SDS-PAGE analysis reports for the eluted frac-
tions obtained from these two columns (Figs. 2 and 5) show that the
efﬁciency of both the puriﬁcation strategies is quite similar. How-
ever, as discussed, the limitations of the traditional IMAC systems
[12], suggest that CFT chromatography could be better alternative
to the traditional IMAC techniques. Nevertheless, further study is
required for a detailed comparison between these two techniques.
5. ConclusionsTo the best of our knowledge, this is the ﬁrst study reporting CFT-
binding peptides (CBPs) as tags for the puriﬁcation of recombinant
proteins. The eGFP gene constructs with or without CBPs, H-eGFP,
atogr
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-eGFP-Tag1 and H-eGFP-Tag2, were expressed successfully in
. coli strain BL-21. Expression of the constructs was conﬁrmed
y SDS-PAGE analysis followed by IMAC. Chromatographic experi-
ents were performed to examine the efﬁciency of the CFT column
or the puriﬁcation of the fused proteins under dynamic conditions.
he construct without a CFT-binding peptide, H-eGFP, was not
etained by the CFT column under any of the applied experimen-
al conditions. It is known that eGFP is a hydrophobic protein [51],
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